Abstract
Cardiac cell regeneration from endogenous cardiac stem cells (CSCs) following MI is rather low. Therefore, identifying mechanisms to boost endogenous CSC activation and participation in cardiac repair appears to be the most promising strategy for MI patients. We previously engineered tissue inhibitor of metalloproteinases-1 (TIMP-1) overexpressing embryonic stem (ES-TIMP-1) cells and transplanted them into the infarcted murine heart. Collected data demonstrated that TIMP-1 enhanced transplanted ES cell engraftment, survival and differentiation into cardiac myocytes post-transplantation. Therefore, we postulated that there may be a new stem cell population present in the heart that is regulated by extracellular protein TIMP-1. Furthermore, we hypothesized that this cell population has a potential for cell proliferation and differentiation into cardiac cell types. Therefore, we isolated CSCs from 4 weeks old C57BL/6 mice and cultured them in vitro in presence of ESCM, ES-TIMP-1-CM or TIMP-1. Our immunostaining data demonstrated the existence of a novel CSC subpopulation, CD63+ve/c-kit+ve. When treated with TIMP-1, these cells showed significantly (p < 0.05) increased proliferation rates compared to control cells, enhanced TIMP-1 receptor (CD63), along with improved expression of phospho and total β-catenin proteins as demonstrated by Western blot analysis. Next, we demonstrate significantly (p < 0.05) improved cardiac myocyte, vascular smooth muscle cell, and endothelial cell differentiation. Furthermore, our RT-PCR data shows increase in cardiac gene (GATA-4, Mef2C, and Nkx-2.5) expression when compared to ESCM and control cells. Collectively, these data, for the first time, establish the existence of a new CD63+ve/c-kit+ve CSC subpopulation that has a significant potential for proliferation and differentiation into cardiac cell types once stimulated with TIMP-1.
References
Abdelli LS, Merino H, Rocher CM et al (2012) Cell therapy in the heart. Can J Physiol Pharmacol 90:307–315
Anversa P, Leri A, Kajstura J (2006) Cardiac regeneration. J Am Coll Cardiol 47:1769–1776
Bergmann O, Bhardwaj RD, Bernard S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98–102
Dawn B, Stein AB, Urbanek K et al (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 102:3766–3771
Singla DK, Singla RD, McDonald DE (2008) Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am J Physiol Heart Circ Physiol 295:H907–H913
Koudstaal S, Jansen Of Lorkeers SJ, Gaetani R et al (2013) Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med 2:434–443
Rajala K, Pekkanen-Mattila M, Alto-Setala K (2011) Cardiac differentiation of pluripotent stem cells. Stem Cells Int 2011:383709
Glass C, Singla DK (2012) Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction. Cell Transpl 21:1931–1944
Yan B, Abdelli LS, Singla DK (2011) Transplanted induced pluripotent stem cells improve cardiac function and induce neovascularization in the infarcted hearts of db/db mice. Mol Pharm 8:1602–1610
Merino H, Singla DK (2014) Notch-1 mediated cardiac protection following embryonic and induced pluripotent stem cell transplantation in doxorubicin-induced heart failure. PLoS One 9:e101024
Long X, Singla DK (2013) Inactivation of Klf5 by zinc finger nuclease downregulates expression of pluripotent genes and attenuates colony formation in embryonic stem cells. Mol Cell Biochem 382:113–119
Leri A, Kajstura J, Anversa P (2005) Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85:1373–1416
Kopitz C, Gerg M, Bandapalli OR et al (2007) Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67:8615–8623
Egea V, Zahler S, Rieth N et al (2012) Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 109:E309–E316
Jung KK, Liu XW, Chirco R et al (2006) Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J 25:3934–3942
Singla DK, Singla RD, Lamm S et al (2011) TGF-beta2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium. Am J Physiol Heart Circ Physiol 300:H1442–H1450
Moore CS, Milner R, Nishiyama A et al (2011) Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci 31:6247–6254
Collot-Teixeira S, Barbatis C, Bultelle F et al (2008) CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI. J Biomed Biotechnol 2008:813236
Doyle EL, Ridger V, Ferraro F et al (2011) CD63 is an essential cofactor to leukocyte recruitment by endothelial P-selectin. Blood 118:4265–4273
Dodou E, Xu SM, Black BL (2003) mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech Dev 120:1021–1032
Durocher D, Charron F, Warren R et al (1997) The cardiac transcription factors Nk2–5 and GATA-4 are mutual cofactors. EMBO J 16:5687–5696
Acknowledgments
The authors are thankful to Reetu Singla and Jing Wang for their technical assistance in the paper.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the University of Central Florida (UCF) Institutional Animal Care and Use Committee (IACUC) ethical standards. This article does not contain any studies with human participants performed by any of the authors.
Funding
This work was supported, in part, by Grants from the National Institute of Health [1R01HL090646-01, and 5R01HL094467-02 to DKS].
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdelli, L.S., Singla, D.K. A CD63+ve/c-kit+ve stem cell population isolated from the mouse heart. Mol Cell Biochem 406, 101–109 (2015). https://doi.org/10.1007/s11010-015-2428-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-015-2428-9